| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/26/2004 | US20040039214 Method for the production of tetrahydrofuran |
| 02/26/2004 | US20040039213 Supplying to the first hydrogenation zone a maleic acid feedstock, reacting feedstock with hydrogen in presence of hydrogenation catalyst to produce succininc acid, reacting in second zone the product with hydrogen and IInd catalyst |
| 02/26/2004 | US20040039064 Treating and/or preventing alzheimer's disease and other neurodegenerative diseases; beta-secretase inhibitors |
| 02/26/2004 | US20040039060 Capable of chelating both of the two divalent metal ions at the same time, a prodrug or a solvate |
| 02/26/2004 | US20040039050 Formulating phenanthro(1,2-b)-furan compound for eliminating hyperammonemia in the brain tissue for treating early stage Alzheimer's disease |
| 02/26/2004 | US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040038977 Treating arthritis, pain and cancer |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038857 Treating the cell with a cholinergic agonist in an amount sufficient to decrease the amount of the proinflammatory cytokine that is released from the cell, wherein the cell is a macrophage |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | US20040035715 Preparation of butanetetracarboxylic acid derivatives by coupled electrosynthesis |
| 02/26/2004 | DE10232020A1 Neurorezeptoraktive Heteroarencarboxamide Neuroreceptor Active Heteroarencarboxamide |
| 02/26/2004 | CA2495956A1 Sulfonamides as potassium channel blockers |
| 02/26/2004 | CA2495784A1 Furanone derivatives and methods of making same |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390339A2 Process for the preparation of 7-substituted 3-alkyl-3h-isobenzofuran-1-one derivatives |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1178986B1 Furanone derivatives as inhibitors of cathepsin s |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | CN1478089A Substituted derivatives of aminofuran-2-Y1-acetic acid and aminothien-2-Y1-acetic acid and use thereof for treating migraines and pain |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477957A Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 02/25/2004 | CN1477956A Crytotanshinone for preventing and delaying early senile dementia |
| 02/25/2004 | CN1477103A Chird sugarapple lactone compound modified by ether bond, its synthesis method and application |
| 02/25/2004 | CN1477102A Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method |
| 02/25/2004 | CN1139627C Phenol-free stabilization of polyolefin fibres |
| 02/25/2004 | CN1139587C Cosmetic preparation containing light stable UV-A light filter agent |
| 02/25/2004 | CN1139567C Process for prodn, of 1,4-butanediol, gamma-butyrolactone and tetrahydrofuran |
| 02/25/2004 | CN1139563C Method for producing mixtures of 1,4-butanediol, tetrahydrofuran and gamma-butyrolactone |
| 02/25/2004 | CN1139426C Oxidative reaction using mixed conductive oxygen selective membrane |
| 02/24/2004 | US6696604 Oxidizing pseudocumene in presence of a solvent and a catalyst comprising multivalent metals to produce trimellitic acid; crystallizing and filtering; dehydrating to produce trimeillitic anhydride; distillation |
| 02/24/2004 | US6696573 Synthesis of such as 2-(n-(2-(9h-carbazol-2-yloxy)ethyl))-amino-1-((3 -methylsulfonylamino)phenyl)ethanol with enhanced optical purity |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | US6696217 Acrylated ester polymer |
| 02/24/2004 | US6696110 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/19/2004 | WO2004014966A1 Microstructure chain transfer agents for anionic polymerization |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014833A2 Method for producing maleic anhydride |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014821A1 Method for the separation of intermediates which may be used for the preparation of escitalopram |
| 02/19/2004 | WO2004000793A3 Aminoacetonitrile derivatives suitable for controlling parasites |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | WO2003051857A3 Furanone synthesis |
| 02/19/2004 | US20040034240 Method for the hydrogenation of maleic anhydride and related compounds in two serial reaction zones |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | US20040034220 5-Nitrobenzofurans |
| 02/19/2004 | US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease |
| 02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034027 E.g.N-(carbamimidoylphenyl)-N'-((1-(4-nitrophenyl)ethyl-2-phenyl -malonamide formate; reversible enzyme inhibitors of blood factor VIIa; a strong antithrombotic to treat thrombo-embolic diseases and restenoses; cardiovascular disorders |
| 02/19/2004 | DE10235355A1 Production of maleic anhydride, useful for the production of gamma-butyrolactone, by heterogeneous catalytic gas phase oxidation of hydrocarbons with oxygen-containing gas in a reaction zone cooled by a heat exchange medium |
| 02/19/2004 | CA2495067A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | CA2494827A1 Cannabinoid receptor ligands |
| 02/19/2004 | CA2493621A1 Method for producing maleic anhydride |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389198A2 Process for the preparation of prostaglandins and analogues thereof |
| 02/18/2004 | EP1389176A1 Method for producing ketones from carboxylic acid anhydrides |
| 02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1088820B1 Process for the preparation of 3-hydroxytetrahydrofuran |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | CN1476425A Production process of butane tetra carboxylic acid derivatives by means of coupled electrosynthesis |
| 02/18/2004 | CN1475486A Chiral 3-aryl benzo phthalein kind compound, synthesis method and use |
| 02/18/2004 | CN1138819C Bis(triaklyl trimellitic anhydride) derivative and polyesterimide for optical communications |
| 02/18/2004 | CN1138768C Method for preparation of citalopram |
| 02/18/2004 | CN1138765C Oxazolidinone antibacterial agents having thiocarbonyl functionality |
| 02/18/2004 | CN1138755C Cyclic amino acids and derivs thereof useful as pharmaceutical agents |
| 02/18/2004 | CN1138752C Novel carboxylic ester derivatives, process for producing same, and insecticide or insectifuge contg. same |
| 02/17/2004 | US6693209 Synthesis of anhydroglycitol esters of improved colour |
| 02/17/2004 | US6693128 Substituted dicinnamoylquinides and their use in augmentation of adenonsine function |
| 02/17/2004 | US6693127 Pharmaceutical compositions of arglabin and arglabin derivatives |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693117 Compounds with analgesic effect |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/17/2004 | US6693092 Herbicides; pesticides |
| 02/17/2004 | US6692944 Alkoxyhalogentating racemic citronellol; dehydrohalogenating to 3-octenol derivative; acylating; biocatalytically resolving isomers; hydrolyzing and cyclizing |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/12/2004 | WO2004013117A1 Bicyclic cylopentanone and cyclopentenone derivatives as potent activators of hsf |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004013087A1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 02/12/2004 | WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | WO2004013080A1 Spirobifluorene derivatives, their preparation and uses thereof |
| 02/12/2004 | WO2004013079A1 Ketocampholenic acid derivatives and their use in fragrance and flavour applications |
| 02/12/2004 | WO2004013069A1 A process for the optical resolution of a precursor of sclareolide |
| 02/12/2004 | WO2004012736A1 Biaryl compounds having anti-infective activity |
| 02/12/2004 | WO2004012656A2 Thiophene and furan derivatives as prostaglandin agonists and use thereof |